Summary
This 8-K filing by MetLife Inc. on February 10, 2003, primarily discloses an increase in its provision for asbestos-related claims and provides an update on the status of these claims. The company, through its subsidiary Metropolitan Life Insurance Company, is facing a significant number of lawsuits related to asbestos exposure. These claims are not from direct involvement in asbestos product manufacturing or insurance for such companies, but rather from allegations concerning the company's research and publications between the 1920s and 1950s regarding asbestos health risks. MetLife Inc. maintains a strong defense against these claims, asserting it owed no duty to plaintiffs and lacked direct involvement in the products causing harm. Despite believing it has meritorious defenses and having no adverse monetary judgments to date, the company has historically settled most cases due to litigation risks and expenses. The filing highlights a substantial increase in the number of pending claims and a corresponding increase in settlement payments. Consequently, MetLife has significantly increased its recorded liability for asbestos-related claims by $402 million to approximately $1.225 billion as of December 31, 2002, reflecting both an acceleration in claim reporting and an increase in the total number of expected claims.
Key Highlights
- 1MetLife Inc. has increased its provision for asbestos-related claims by $402 million, bringing the total recorded liability to approximately $1.225 billion as of December 31, 2002.
- 2The company attributes this increase to an acceleration in claim reporting and a greater expectation of the total number of future asbestos-related claims.
- 3Metropolitan Life Insurance Company is a defendant in approximately 106,500 asbestos personal injury claims as of December 31, 2002, a significant rise from previous years.
- 4Settlement payments for asbestos claims increased to $95.1 million in 2002, compared to $90.7 million in 2001 and $71.1 million in 2000.
- 5MetLife maintains it has never manufactured, produced, distributed, or sold asbestos products, nor insured companies directly involved in these activities.
- 6The company believes it has strong legal defenses and has not suffered adverse judgments, with historical settlements being a strategic decision to manage litigation risks.
- 7The company has excess insurance policies that could cover losses up to $1.5 billion, exceeding a $400 million self-insured retention, although current policy performance has reduced expected reimbursements by $42 million.